‹ Back to screener

ALKEM.NS Alkem Laboratories Ltd.

Healthcare

Price history

2025-08-21 ₹5422.00
2026-08-21 ₹5376.00
Change over window -0.85%

Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.

Technical indicators

ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.

MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.

Delivery volume

Latest (2026-08-28) 66.7%
Trailing 20-day average 53.0%
Date Traded Qty Delivery Qty Delivery %
2026-08-28 231100 154134 66.70%
2026-08-27 166838 123018 73.74%
2026-08-26 44001 21155 48.08%
2026-08-25 48065 26325 54.77%
2026-08-24 46339 26045 56.21%
2026-08-21 76854 42574 55.40%
2026-08-20 85369 64857 75.97%
2026-08-19 213076 140641 66.01%
2026-08-18 127028 35682 28.09%
2026-08-17 153275 54620 35.64%
2026-08-14 635598 201122 31.64%
2026-08-13 33025 15244 46.16%
2026-08-12 110443 65679 59.47%
2026-08-11 115598 55745 48.22%
2026-08-10 82544 43651 52.88%
2026-08-07 76165 24114 31.66%
2026-08-06 109477 68284 62.37%
2026-08-05 88646 45766 51.63%
2026-08-04 37653 20478 54.39%
2026-08-03 122664 75373 61.45%

Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers ALKEM.NS to fetch more history.

Insider trading activity

Disclosed Person Category Type Mode Quantity Value (₹) Resulting stake
29 Mar 2022 Deepak Kumar Singh Employees/Designated Employees Sell Market Sale 25000 90235579 2.41% XBRL
08 Mar 2022 Mritunjay Kumar Singh Director Buy Market Purchase 3357 10691874 6.38% XBRL
08 Mar 2022 Mritunjay Kumar Singh Director Buy Market Purchase 1643 5188662 6.38% XBRL
25 Feb 2022 Dhananjay and Madhurima Singh Trust Promoters Buy Market Purchase 1050 3438750 0.00% XBRL
23 Feb 2022 Dhananjay and Madhurima Singh Trust Promoters Buy Market Purchase 2000 6591741 0.00% XBRL
30 Dec 2021 Deepak Kumar Singh Employees/Designated Employees Sell Market Sale 2000 6982333 2.43% XBRL
27 Dec 2021 Deepak Kumar Singh Employees/Designated Employees Sell Market Sale 2000 6874627 2.43% XBRL
23 Dec 2021 Deepak Kumar Singh Employees/Designated Employees Sell Market Sale 5000 17179131 2.44% XBRL
02 Dec 2021 Jayanti Sinha Promoter Group Sell Gift 2000000 0 4.30% XBRL
18 Nov 2021 Deepak Kumar Singh Employees/Designated Employees Sell Market Sale 5000 17862762 2.44% XBRL
05 Oct 2021 Satish Kumar Singh Promoters Buy Off Market 50267 0 0.06% XBRL
05 Oct 2021 Balmiki Prasad Singh Director Buy Off Market 50266 0 0.10% XBRL
29 Sep 2021 Deepak Kumar Singh Employees/Designated Employees Sell Market Sale 4000 15696056 2.44% XBRL
24 Sep 2021 Deepak Kumar Singh Employees/Designated Employees Sell Market Sale 4000 15672126 2.45% XBRL
21 Sep 2021 Deepak Kumar Singh Employees/Designated Employees Sell Market Sale 4789 18505344 2.45% XBRL
15 Sep 2021 Alok Kumar Employees/Designated Employees Buy Off Market 1355769 0 2.31% XBRL
14 Sep 2021 Mr. Ashok kumar Employees/Designated Employees Buy Off Market 1355769 0 2.31% XBRL
25 Jun 2021 Balmiki Prasad Singh Director Buy Off Market 250 0 0.06% XBRL
25 Jun 2021 Satish Kumar Singh Promoters Buy Off Market 250 0 0.02% XBRL
22 Jun 2021 Dhananjay Kumar Singh Promoters Buy Gift 2052305 0 7.96% XBRL

SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers ALKEM.NS to fetch more.

Ratios as of FY2025-26 (Annual) · Price ₹5400.00 INR (live) · fetched 2026-08-23 21:34 price stale

Extract this company (financials + ratios + citations): CSV · XLSX

Ratios

P/E
28.05
P/E = Price / EPS
Source trace
P/E = Price / (ProfitOrLossAttributableToOwnersOfParent / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) → ₹5,400.00 / (₹23,018,011,000 / 119,550,000 shares) = ₹5,400.00 / ₹192.54 EPS
FY2025-26 · Annual filing
ROE
16.66%
ROE = Net Income / Shareholder Equity
Source trace
ROE = ProfitOrLossAttributableToOwnersOfParent / EquityAttributableToOwnersOfParent → ₹23,018,011,000 / ₹138,201,000,000 = 16.66%
FY2025-26 · Annual filing
Debt/Equity
0.12
Debt/Equity = Total Debt / Shareholder Equity
Source trace
Debt/Equity = BorrowingsCurrent + BorrowingsNoncurrent / EquityAttributableToOwnersOfParent → ₹16,235,000,000 / ₹138,201,000,000 = 0.12
FY2025-26 · Annual filing
Current Ratio
2.55
Current Ratio = Current Assets / Current Liabilities
Source trace
Current Ratio = CurrentAssets / CurrentLiabilities → ₹122,105,200,000 / ₹47,827,000,000 = 2.55
FY2025-26 · Annual filing
ROCE
20.76%
ROCE = EBIT / (Shareholder Equity + Total Debt)
Source trace
ROCE = ProfitBeforeExceptionalItemsAndTax + FinanceCosts / (EquityAttributableToOwnersOfParent + BorrowingsCurrent + BorrowingsNoncurrent) → ₹32,065,000,000 / (₹138,201,000,000 + ₹16,235,000,000) = 20.76%
FY2025-26 · Annual filing
Dividend Yield
0.95%
Dividend Yield = (Dividends Paid / Diluted Shares Outstanding) / Price

This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.

Source trace
Dividend Yield = (|DividendsPaidClassifiedAsFinancingActivities| / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) / Price → (₹6,137,000,000 / 119,550,000 shares) / ₹5,400.00 = ₹51.33 / ₹5,400.00
FY2025-26 · Annual filing

Growth & earnings trend

Revenue & Profit CAGR

Revenue (3y, 3.0y actual) 8.2%
Net Profit (3y) 32.7%
Revenue (5y, 3.0y actual) 8.2%
Net Profit (5y) 32.7%
Revenue (10y, 3.0y actual) 8.2%
Net Profit (10y) 32.7%

Operating Margin Trend

Expanding

FY2022-23 13.1%
FY2023-24 17.8%
FY2024-25 20.4%
FY2025-26 21.8%

ROCE Trajectory

FY2022-23 14.0%
FY2023-24 18.9%
FY2024-25 19.6%
FY2025-26 20.1%

Earnings Quality

⚠ Persistent profit/cash gap

Net Profit CAGR 32.73% vs CFO CAGR 5.27% over 3.0y (2023-03-31 → 2026-03-31); most recent year: Net Profit +6.30% vs CFO +2.62%

Sector-Relative Percentile (Healthcare)

ROE 61th
ROCE 67th
Debt/Equity 48th
P/E 85th

Quarterly trend

Revenue Net Profit Net Profit (loss quarter)
Metric (to shareholders basis) Q4 FY2023-24 Q1 FY2024-25 Q2 FY2024-25 Q3 FY2024-25 Q4 FY2024-25 Q1 FY2025-26 Q2 FY2025-26 Q3 FY2025-26 Q4 FY2025-26 Q1 FY2026-27 Source
Revenue ₹29.36 Bn ₹30.32 Bn ₹34.15 Bn ₹33.74 Bn ₹31.44 Bn ₹33.71 Bn ₹40.01 Bn ₹37.37 Bn ₹36.03 Bn ₹37.40 Bn RevenueFromOperations
Net Profit ₹2.94 Bn incl. minority ₹3.04 Bn ₹5.45 Bn incl. minority ₹5.50 Bn ₹6.89 Bn incl. minority ₹7.02 Bn ₹6.26 Bn incl. minority ₹6.41 Bn ₹3.06 Bn incl. minority ₹3.22 Bn ₹6.64 Bn incl. minority ₹6.68 Bn ₹7.65 Bn incl. minority ₹7.79 Bn ₹6.36 Bn incl. minority ₹6.53 Bn ₹2.36 Bn incl. minority ₹2.51 Bn ₹5.20 Bn incl. minority ₹5.21 Bn ProfitOrLossAttributableToOwnersOfParent

Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers ALKEM.NS to fetch more.

Source document — income statement (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

ProfitOrLossAttributableToOwnersOfParent23018011000.0
PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital119550000.0
Source document — balance sheet (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

CurrentAssets122105200000.0
CurrentLiabilities47827000000.0
EquityAttributableToOwnersOfParent138201000000.0
BorrowingsCurrent + BorrowingsNoncurrent16235000000.0

My notes